These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33710266)

  • 1. Host versus cell-dependent effects of β-arrestin 1 expression in prostate tumorigenesis.
    Adekoya TO; Smith N; Thomas AJ; Lane TS; Burnette N; Rivers EJ; Li Y; Chen XL; Richardson RM
    Carcinogenesis; 2021 May; 42(5):772-783. PubMed ID: 33710266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activator of G protein signaling 3 modulates prostate tumor development and progression.
    Adekoya TO; Smith N; Aladeniyi T; Blumer JB; Chen XL; Richardson RM
    Carcinogenesis; 2019 Dec; 40(12):1504-1513. PubMed ID: 31215992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. βArrestin1 regulates glucocorticoid receptor mitogenic signaling in castration-resistant prostate cancer.
    Purayil HT; Daaka Y
    Prostate; 2022 May; 82(7):816-825. PubMed ID: 35226379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear βArrestin1 regulates androgen receptor function in castration resistant prostate cancer.
    Purayil HT; Zhang Y; Black JB; Gharaibeh R; Daaka Y
    Oncogene; 2021 Apr; 40(14):2610-2620. PubMed ID: 33692468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer.
    Kim Y; Kim J; Jang SW; Ko J
    Oncogene; 2015 Jan; 34(2):226-36. PubMed ID: 24441043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
    Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
    Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Termination of protease-activated receptor-1 signaling by beta-arrestins is independent of receptor phosphorylation.
    Chen CH; Paing MM; Trejo J
    J Biol Chem; 2004 Mar; 279(11):10020-31. PubMed ID: 14699102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P21 and P27 promote tumorigenesis and progression via cell cycle acceleration in seminal vesicles of TRAMP mice.
    Li T; Wang F; Dang Y; Dong J; Zhang Y; Zhang C; Liu P; Gao Y; Wang X; Yang S; Lu S
    Int J Biol Sci; 2019; 15(10):2198-2210. PubMed ID: 31592235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
    da Silva RF; Nogueira-Pangrazi E; Kido LA; Montico F; Arana S; Kumar D; Raina K; Agarwal R; Cagnon VHA
    J Biomed Sci; 2017 May; 24(1):31. PubMed ID: 28499383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
    Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
    Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ron receptor promotes prostate tumor growth in the TRAMP mouse model.
    Thobe MN; Gray JK; Gurusamy D; Paluch AM; Wagh PK; Pathrose P; Lentsch AB; Waltz SE
    Oncogene; 2011 Dec; 30(50):4990-8. PubMed ID: 21625214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.
    Karacosta LG; Foster BA; Azabdaftari G; Feliciano DM; Edelman AM
    J Biol Chem; 2012 Jul; 287(29):24832-43. PubMed ID: 22654108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice.
    Husaini Y; Qiu MR; Lockwood GP; Luo XW; Shang P; Kuffner T; Tsai VW; Jiang L; Russell PJ; Brown DA; Breit SN
    PLoS One; 2012; 7(8):e43833. PubMed ID: 22952779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1.
    Rodriguiz RM; Nadkarni V; Means CR; Pogorelov VM; Chiu YT; Roth BL; Wetsel WC
    Sci Rep; 2021 Sep; 11(1):17690. PubMed ID: 34480046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic modifications of Nrf2 by 3,3'-diindolylmethane in vitro in TRAMP C1 cell line and in vivo TRAMP prostate tumors.
    Wu TY; Khor TO; Su ZY; Saw CL; Shu L; Cheung KL; Huang Y; Yu S; Kong AN
    AAPS J; 2013 Jul; 15(3):864-74. PubMed ID: 23658110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of p21/Cdkn1a confers protective effect against prostate tumorigenesis in transgenic adenocarcinoma of the mouse prostate model.
    Jain AK; Raina K; Agarwal R
    Cell Cycle; 2013 May; 12(10):1598-604. PubMed ID: 23624841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer.
    Jeet V; Ow K; Doherty E; Curley B; Russell PJ; Khatri A
    Prostate; 2008 Apr; 68(5):548-62. PubMed ID: 18247402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
    Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
    J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein alters growth factor signaling in transgenic prostate model (TRAMP).
    Wang J; Eltoum IE; Lamartiniere CA
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):171-80. PubMed ID: 15149738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.